INTERNATIONAL
GROWTH
With NUTRARTIS products we are in the process of entering different international markets, and seeking to connect with business partners who are willing to co-create the new health paradigm.
To certify the quality of CARDIOSMILE and compliance with global regulations, it is certified as:
Our operations follow the principles of Good Manufacturing Practices according to the NSF of the United States (US 21 CFR 110).
MEET CARDIOSMILE
Cardiosmile is comprised of 2 grams of free phytosterol sub-micron particles dispersed in water.
It has been shown to reduce cholesterol, triglycerides and waist perimeter and has been proven to be safe after more than 300.000 units have been delivered around the world without secondary effects. (learn more – link a Clinically proved)
It is easy to use and can be consumed along your favorite foods and drinks and is free from calories, fat, sugars, lactose, gluten, and GMOs.
Most importantly, Cardiosmile is a UNIQUE product: it offers benefits beyond cholesterol reduction, is backed up by clinical data and its process is patented.
MANUFACTURING
Our manufacturing process is based on 10+ years of research enhancing phytosterol crystals’ biological activity without incurring in chemical modifications. Our plant was designed and built in-house, working with industry partners to meet the most stringent GMP guidelines. Our experts jointly accumulate several decades of experience.
WHERE TO BUY
PRODUCTS?
CLINICAL TRIALS
UNIVERSITY OF MANITOBA, CANADÁ, 2014
This study proved the efficacy of CARDIOSMILE, a water-dispersible formulation of free phytosterols versus traditional phytosterol esters, thus supporting the claim that there may be additional advantages in a highly dispersible form of phytosterols in terms of controlling lipid levels. Access the full paper here: Water dispersible plant sterol formulation shows improved effect on lipid profile compared to plant sterol esters (https://www.sciencedirect.com/science/article/abs/pii/S1756464613002454)
UNIVERSITY OF LOS ANDES, CHILE, 2020
This study determined the possible link between a reduction in waist size and triglycerides levels, with an increase in intestinal transit. Lipid and glucose metabolism in patients with metabolic syndrome, differ from healthy people; in particular, lower cholesterol absorption and smaller LDL size reflect the effect of phytosterols on VLDL, and not LDL. Access the full paper here: Effects of Daily Consumption of an Aqueous Dispersion of Free-Phytosterols Nanoparticles on Individuals with Metabolic Syndrome (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468816/)
CECIM, CHILE, 2023
This study showed the effect of a sub-micron dispersion in reducing liver fat and having positive effect on other NASH-pertinent molecular targets (plasma triglycerides, VLDL-P, HDL-P, etc.). It was effective over a range of baseline liver fat levels.
Access the full paper here: Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease (https://www.mdpi.com/2077-0383/12/3/979)
UNIVERSITY OF TORONTO, CANADA, to be published
The purpose of this study is to determine whether a dietary portfolio of cholesterol-lowering foods (viscous fibers, soy protein, plant sterols and nuts) further enhanced by increased levels of monounsaturated fatty acids (MUFA) and low glycemic index foods, together with a structured exercise program, reduce the progression of carotid and coronary atheromatous lesions, low-density lipoprotein cholesterol (LDL-C), and blood pressure, while reducing the number of individuals requiring statins.
ONGOING STUDIES
Part of our philosophy is to continue working on innovation, development, and scientific evidence. This is why we are permanently conducting new studies to prove the effectiveness and new applications of phytosterol sub-micron dispersions.
Learn more about the role of sub-micron phytosterol dispersions by accessing our whitepaper database here